Kiromic Biopharma Inc reports results for the quarter ended in September - Earnings Summary

Kiromic Biopharma

14/03/2022 06:01

* Kiromic Biopharma Inc  KRBP.OQ  reported a quarterly
adjusted
loss of 40 cents​​ per share for the quarter ended in September.
The lone analyst forecast for the quarter was for a loss of 26
cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Kiromic Biopharma Inc shares had fallen by 50.5% this
quarter.
    * The company reported a quarterly loss of $6.12 million.

This summary was machine generated March 14 at 06:01 a.m.  ​All
figures in US dollars unless otherwise stated